Table 1 Clinical characteristics (93 cases)
Characteristic | No. (%) |
|---|---|
Gender | |
Male | 67(72.0) |
Famale | 26(28.0) |
Age (years) | |
median(range) | 57(28–78) |
<60 | 56(60.2) |
≥60 | 37(39.8) |
Pathological type | |
Squamous carcinoma | 27(29.0) |
Adenocarcinoma | 58(62.4)9 |
others | 8(8.6) |
Karnofsky performance status | |
≤80 | 64(68.8) |
>80 | 29(31.2) |
T stage | |
T1–2 | 32(34.4) |
T3–4 | 61(65.6) |
N stage | |
N0–1 | 15(16.1) |
N2–3 | 78(83.9) |
Gross tumor volume (cm3) | |
median(range) | 170(35.8-627.6) |
<170 | 45(48.4) |
≥170 | 48(51.6) |
Metastasis status | |
Multiple organs | 37(39.8) |
Brain | 15(16.1) |
subcutaneous nodules | 2(2.2) |
Distant lymph nodes | 5(5.4) |
Lung | 21(22.6) |
Bone | 24(25.8) |
Liver | 5(5.4) |
Adrenal | 5(5.4) |
Single organ | 56(60.2) |
Brain | 9(9.7) |
subcutaneous nodules | 2(2.2) |
Distant lymph nodes | 3(3.2) |
Lung | 13(14.0) |
Bone | 28(30.1) |
Liver | 1(1.0) |
Radiation dose(Gy) to primary tumor | |
median(range) | 63(40–74) |
<63 | 29(31.2) |
≥63 | 64(68.8) |
Response of primary tumor | |
Complete response | 5(5.4) |
Partial response | 66(71.0) |
Stable | 18(19.4) |
Progressive | 4(4.3) |
No. of chemotherapy cycle | |
4 | 89(95.7) |
5 | 4(4.3) |
Radiotherapy to metastases | |
Yes | 50((53.8) |
No | 43(46.2) |